Spineology has launched its OptiMesh HA Nano implant for interbody fusion, according to a Jan. 13 news release.
The implant is a first-of-its-kind patient-specific expandable implant with a hydroxyapatite nano-surface treatment. It is designed to promote rapid cellular response and establish a three-dimensional bioactive surface area for osseointegration and infection prevention.
“The OptiMesh platform is uniquely built on our conform and expand implant technology that adapts to individual patient anatomy,” Brian Snider, Spineology’s CEO, said in the release. “Now, Spineology delivers a first-of-its-kind solution that integrates a well-studied surface treatment, optimized to support spinal fusion goals, and promote osseointegration.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.